What Seattle Needs: Dealing With Amgen’s Upcoming Departure

Reality bites: Amgen’s (NASDAQ: AMGN) decision to leave Washington state is a serious blow to our local bioscience ecosystem. Those who think that all of those people who got laid off (or choose not to relocate) will be able to find biopharma jobs here in Seattle are kidding themselves. Our community is not large and robust enough that the employees of large companies being acquired or shut down can readily find local re-employment in the biotech arena.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC